On the 11th of November 2020 a contract-based alliance of ENCePP research centres called the SIGMA Consortium was launched. The launch of the SIGMA Consortium heralds a new era of collaboration to better understand safety and effectiveness of medical interventions. Research institutions compete for resources to carry out research. SIGMA aims to address this challenge by integrating expertise and data from multiple European Research Centres. The new collaborative research initiative, designed to be the best ‘go-to’ organisation for comprehensive and rigorous methodological research, is being launched to enable multi-country studies using common analyses to study responses to treatments in large populations.
SIGMA executive committee start up members Prof Ron Herings (Netherlands) and Dr Susana Perez-Gutthann (Spain) said “The benefits and risks of treatments are of concern to every citizen. Our objective is to clarify and quantify these treatment effects for the citizens of Europe.”